Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025 - Scorecard - MDSpire

Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025

  • By

  • Darren M. C. Poon

  • Philip W. K. Kwong

  • Samson Y. S. Chan

  • Brian S. H. Ho

  • Martin H. C. Lam

  • K. S. Law

  • Angus K. C. Leung

  • Clarence L. H. Leung

  • David K. W. Leung

  • W. K. Ma

  • Barry B. W. Wo

  • Kenneth C. W. Wong

  • Philip Y. Wu

  • Peter K. F. Chiu

  • April 23, 2026

  • 0 min

Share

Clinical Scorecard: Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025

At a Glance

CategoryDetail
Condition
Key MechanismsSurgical and (neo)adjuvant treatment, immunotherapy, targeted therapies, and emerging therapies.
Target Population
Care Setting

Key Highlights

  • active_surveillance

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with locally advanced and metastatic renal cell carcinoma.

          Combination therapies and novel agents are critical for improving outcomes.

          Clinical Best Practices

          • multidisciplinary_discussions

          References

          Original Source(s)

          Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025

          • by Darren M. C. Poon, Philip W. K. Kwong, Samson Y. S. Chan, Brian S. H. Ho, Martin H. C. Lam, K. S. Law, Angus K. C. Leung, Clarence L. H. Leung, David K. W. Leung, W. K. Ma, Barry B. W. Wo, Kenneth C. W. Wong, Philip Y. Wu, Peter K. F. Chiu

          • April 23, 2026

          Related Content

          Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

          FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

          Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”